Innovation & Access at the EU High Level Event on Global Health

On the 10th and 11th of June, the Global Health Conference took place in Brussels, stemming from the Global Health Communication and Council Conclusions on Global Health, which were driven by the Spanish Presidency. For many, this new EU policy on global health represents a breakthrough as the EU takes an unprecedented stance on global health issues,

Review of conflict of interest policies in three European medicines regulation agencies

HAI Europe members Dr. Orla O’Donovan and Dr. Joel Lexchin published the article ‘Prohibiting or ‘managing’ conflicts of interest (COI)? A review of policies and procedures in three European medicines regulation agencies’ in Social Science & Medicine (2010).

The authors conclude that drug regulatory agencies, including the European Medicine Agency,

Quito Declaration

IV Meeting of Latin America & Caribbean – Global Alliance for Access to Medicines

DECLARATION

Quito, Ecuador 22 – 24 April 2010

Organizations of the Latin American and Caribbean (LAC) – Global Alliance for Access to Medicines reaffirm their commitment to work to ensure universal access to medicines,

Quito Declaration

DECLARATION

Quito, Ecuador 22 – 24 April 2010

Organizations of the Latin American and Caribbean (LAC) – Global Alliance for Access to Medicines reaffirm their commitment to work to ensure universal access to medicines, in the belief that medicines are enabling factors for the full exercise of the right to life.

EU Ombudsman: Transparency rules apply to all documents held by EMA

In 2008, an Irish citizen asked the European Medicines Agency for access to reports on suspected adverse reactions to a drug used to treat severe forms of acne. The EMA refused this request and the citizen turned to the EU Ombudsman, Mr. P. Nikiforos Diamandouros.

Diamandouros has concluded that:

“Since its work has a direct impact on the health of European citizens,

Patient groups not only for sick people's interests – says Portuguese sociologist

Patient organisations are instrumental to social movements, but they can also be a vehicle for commercial interests, cautions Portuguese sociologist Noemia Lopes of the Instituto Superior de Ciencias de Saude Egas Moniz.

Drawing on several examples from Portugal, Lopes and others cite disclosure policies, donor-recipient interaction guidelines and maintaining a variety of income sources as strategies that could diffuse any dependency on corporate cash.

START TYPING AND PRESS ENTER TO SEARCH